GH Competitors & Alternatives
Compare Guardant Health Inc with similar stocks in the same industry
Diagnostics & Research
GH
Main Stock$128.83
Tradestie Score
56
Market Cap
$7.81B
Revenue Growth
0.5%
Analyst Upside
+10.1%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LH
Labcorp Holdings Inc.
|
$254.43
|
$23.19B | 22.5 | 60 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$228.80
|
$22.18B | - | 62 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$193.58
|
$20.36B | 21.5 | 56 | Compare |
|
WAT
Waters Corp
|
$358.25
|
$19.04B | 45.2 | 55 | Compare |
|
ILMN
Illumina Inc
|
$161.38
|
$15.72B | 29.4 | 55 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$455.66
|
$15.28B | 28.9 | 55 | Compare |
|
ICLR
Icon Plc
|
$140.73
|
$14.96B | 50.2 | 51 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$99.04
|
$10.65B | 48.1 | 56 | Compare |
|
QGEN
QIAGEN N.V.
|
$36.28
|
$10.04B | 18.9 | 60 | Compare |
More GH Analysis
Data updated: Jun 23, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry